Summary by Moomoo AI
Cybin Inc., a clinical-stage biopharmaceutical company, announced that its CEO, Doug Drysdale, will participate in a fireside chat at the Alliance Global Partners Healthcare Company Showcase on May 21, 2024. The event, which will be held virtually, is set to feature a live webcast of Mr. Drysdale's presentation at 12:40 p.m. ET. Cybin, known for its focus on developing psychedelic-based treatments for mental health conditions, is currently working on CYB003 and CYB004, investigational compounds for major depressive disorder and generalized anxiety disorder, respectively. The company, founded in 2019, operates across multiple countries including Canada, the United States, the United Kingdom, the Netherlands, and Ireland. The webcast will be accessible online and will also be archived on Cybin's investor relations website.